A unique bacterial strain isolated from a patient with pelvic pain may represent a promising path to treating prostate cancer with immunotherapy, according to a Northwestern Medicine study published in Nature Communications. A tumor that was not treated with CP1 (above) and a tumor that was treated with CP1 (below). T-cells are in red, indicating immune...